Aimovig Approved to Prevent Migraines

FRIDAY, May 18, 2018 — Aimovig (erenumab-aooe) has been approved by the U.S. Food and Drug Administration to prevent migraine headaches in adults. Aimovig is the first FDA-approved preventive migraine treatment in a new class of drugs that work by blocking the activity of calcitonin gene-related peptide, a molecule involved in migraine attacks, the agency […]

Unique nanotechnology method to simplify skin disease diagnosis

In a new SLAS Technology auto-commentary, two authors of an article recently published in Nature Biomedical Engineering (“Abnormal Scar Identification with Spherical Nucleic Acid Technology” – www.nature.com/articles/s41551-018-0218-x) share more insight into their unique method for skin disease diagnosis using NanoFlare nanotechnology. In particular, the authors address point-of-care diagnosis and image acquisition, which are the primary […]